Table 2.
Method | Total ASC-US | Biopsies | % Biopsied | CIN 1 | CIN 2/3 | ||
Number | % of Total | Number | % of Total | ||||
TIS | 463 | 209 | 45.1% | 69 | 14.9% | 24 | 5.18% |
MS | 965 | 435 | 45.1% | 156 | 16.2% | 49 | 5.07% |
Follow-up biopsy results for the ASC-US cases screened by the TIS and by MS alone among women positive for HR-HPV.